Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Idiopathic Pulmonary Fibrosis"" wg kryterium: Temat


Tytuł:
Exosomal circRNAs in the plasma serve as novel biomarkers for IPF diagnosis and progression prediction.
Autorzy:
Gan W; Department of Emergency, Nanjing Drum Tower Hospital, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, China.; Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of China Pharmaceutical University, Nanjing, 210008, China.
Song W; Department of Emergency, Nanjing Drum Tower Hospital, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, China.
Gao Y; Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of China Pharmaceutical University, Nanjing, 210008, China.
Zheng X; Department of Emergency, Nanjing Drum Tower Hospital, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, China.
Wang F; Department of Emergency, Nanjing Drum Tower Hospital, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, China.
Zhang Z; Department of Thoracic Surgery, Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, 210008, China.
Zen K; Department of Emergency, Nanjing Drum Tower Hospital, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, China. .
Liang H; Department of Emergency, Nanjing Drum Tower Hospital, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, China. .
Yan X; Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of China Pharmaceutical University, Nanjing, 210008, China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 Mar 10; Vol. 22 (1), pp. 264. Date of Electronic Publication: 2024 Mar 10.
Typ publikacji:
Journal Article
MeSH Terms:
RNA, Circular*/genetics
Idiopathic Pulmonary Fibrosis*/diagnosis
Idiopathic Pulmonary Fibrosis*/genetics
Animals ; Mice ; Humans ; Biomarkers ; Prognosis ; Up-Regulation
Czasopismo naukowe
Tytuł:
Age at menarche and idiopathic pulmonary fibrosis: a two-sample mendelian randomization study.
Autorzy:
Cao J; Department of Respiratory and Critical Care Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, Jiangsu, China.
Ma Y; Department of Neurology, Third Affiliated Hospital of Soochow University, Changzhou, 213003, Jiangsu, China.
Zhao W; Department of Respiratory and Critical Care Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, Jiangsu, China.
Feng C; Department of Respiratory and Critical Care Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, Jiangsu, China. chunlai_.
Pokaż więcej
Źródło:
BMC pulmonary medicine [BMC Pulm Med] 2024 Mar 06; Vol. 24 (1), pp. 117. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:
Journal Article
MeSH Terms:
Menarche*/genetics
Idiopathic Pulmonary Fibrosis*/epidemiology
Idiopathic Pulmonary Fibrosis*/genetics
Humans ; Female ; Male ; Mendelian Randomization Analysis ; Estrogens ; Odds Ratio
Czasopismo naukowe
Tytuł:
Tetrahedral DNA loaded siCCR2 restrains M1 macrophage polarization to ameliorate pulmonary fibrosis in chemoradiation-induced murine model.
Autorzy:
Li C; Centre for Translational Research in Cancer, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610042, China.
Feng X; Centre for Translational Research in Cancer, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610042, China.
Li S; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
He X; School of Clinical Medicine, Chengdu Medical College, Chengdu 610500, China.
Luo Z; Department of Pulmonary and Critical Care Medicine, Wenjiang Hospital of Sichuan Provincial People's, Chengdu 611138, China.
Cheng X; Centre for Translational Research in Cancer, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610042, China.
Yao J; Centre for Translational Research in Cancer, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610042, China.
Xiao J; Centre for Translational Research in Cancer, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610042, China.
Wang X; Department of Neurology, West China Hospital, Sichuan University, Chengdu 610041, China.
Wen D; Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Liu D; Centre for Translational Research in Cancer, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610042, China.
Li Y; School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China.
Zhou H; School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu 610056, China.
Ma L; Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Lin T; Centre for Translational Research in Cancer, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610042, China.
Cai X; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China; College of Biomedical Engineering, Sichuan University, Chengdu 610041, China.
Lin Y; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China; College of Biomedical Engineering, Sichuan University, Chengdu 610041, China. Electronic address: .
Guo L; Department of Pulmonary and Critical Care Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China. Electronic address: .
Yang M; Centre for Translational Research in Cancer, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610042, China. Electronic address: .
Pokaż więcej
Źródło:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2024 Mar 06; Vol. 32 (3), pp. 766-782. Date of Electronic Publication: 2024 Jan 24.
Typ publikacji:
Journal Article
MeSH Terms:
Macrophages*
Idiopathic Pulmonary Fibrosis*/chemically induced
Idiopathic Pulmonary Fibrosis*/genetics
Humans ; Mice ; Animals ; Disease Models, Animal ; Fibrosis ; DNA ; Bleomycin
Czasopismo naukowe
Tytuł:
Mechanical ventilation in patients with idiopathic pulmonary fibrosis in Korea: a nationwide cohort study.
Autorzy:
Sim JK; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
Moon SJ; Smart Health-Care Center, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
Choi J; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
Oh JY; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
Lee YS; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
Min KH; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
Hur GY; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
Lee SY; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
Shim JJ; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
The Korean journal of internal medicine [Korean J Intern Med] 2024 Mar; Vol. 39 (2), pp. 295-305. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Respiration, Artificial*/adverse effects
Idiopathic Pulmonary Fibrosis*/diagnosis
Idiopathic Pulmonary Fibrosis*/therapy
Humans ; Cohort Studies ; Retrospective Studies ; Republic of Korea/epidemiology
Czasopismo naukowe
Tytuł:
C-reactive protein as a candidate biomarker in fibrotic interstitial lung disease.
Autorzy:
Cottin V; Department of Respiratory Medicine, National Reference Centre for Rare Pulmonary Diseases, member of ERN-LUNG, Louis Pradel Hospital, Hospices Civils de Lyon, Lyon, France.; UMR 754, INRAE, Claude Bernard University Lyon 1, Lyon, France.
Valenzuela C; Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid, Spain.
Pokaż więcej
Źródło:
Respirology (Carlton, Vic.) [Respirology] 2024 Mar; Vol. 29 (3), pp. 195-198. Date of Electronic Publication: 2024 Jan 31.
Typ publikacji:
Editorial
MeSH Terms:
Lung Diseases, Interstitial*/diagnosis
Lung Diseases, Interstitial*/pathology
Idiopathic Pulmonary Fibrosis*/diagnosis
Idiopathic Pulmonary Fibrosis*/pathology
Humans ; C-Reactive Protein ; Fibrosis ; Biomarkers ; Lung/pathology
Opinia redakcyjna
Tytuł:
Antifibrotic effects of vitamin D3 on human lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
Autorzy:
Voisin T; Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, France.
Joannes A; Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, France.
Morzadec C; Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, France.
Lagadic-Gossmann D; Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, France.
Naoures CL; Department of pathology and cytology, Rennes University Hospital, France.
De Latour BR; Department of Thoracic, cardiac and vascular surgery, Rennes University Hospital, France.
Rouze S; Department of Thoracic, cardiac and vascular surgery, Rennes University Hospital, France.
Jouneau S; Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, France; Department of Respiratory Diseases, Competence Center for Rare Pulmonary Diseases, Rennes University Hospital, France.
Vernhet L; Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, France. Electronic address: .
Pokaż więcej
Źródło:
The Journal of nutritional biochemistry [J Nutr Biochem] 2024 Mar; Vol. 125, pp. 109558. Date of Electronic Publication: 2024 Jan 05.
Typ publikacji:
Journal Article
MeSH Terms:
Lung*
Idiopathic Pulmonary Fibrosis*/drug therapy
Idiopathic Pulmonary Fibrosis*/metabolism
Idiopathic Pulmonary Fibrosis*/pathology
Humans ; Animals ; Mice ; Fibroblasts/metabolism ; Cell Differentiation ; Lactates/pharmacology
Czasopismo naukowe
Tytuł:
Psoriasis may increase the risk of idiopathic pulmonary fibrosis: a two-sample Mendelian randomization study.
Autorzy:
Chen L; Department of Pediatrics, Xiangya Hospital, Central South University, Hunan, 410008, China.
Wei Y; Key Laboratory of Digestive System Tumors of Gansu Province, Second Hospital of Lanzhou University, Lanzhou, 730000, China.
Hu M; Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
Liu Y; Department of Pediatrics, Xiangya Hospital, Central South University, Hunan, 410008, China.
Zheng X; Department of Pediatrics, Xiangya Hospital, Central South University, Hunan, 410008, China. .
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2024 Feb 26; Vol. 25 (1), pp. 101. Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:
Journal Article
MeSH Terms:
Idiopathic Pulmonary Fibrosis*/diagnosis
Idiopathic Pulmonary Fibrosis*/epidemiology
Idiopathic Pulmonary Fibrosis*/genetics
Psoriasis*/diagnosis
Psoriasis*/epidemiology
Psoriasis*/genetics
Humans ; Genome-Wide Association Study ; Mendelian Randomization Analysis ; Nonoxynol
Czasopismo naukowe
Tytuł:
Localized Administration of Bcar3 siRNA via Nano-Self-Assembly to Treat Idiopathic Pulmonary Fibrosis by Disrupting Macrophage-Fibroblast Crosstalk.
Autorzy:
Zeng C; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China.
Wang Q; Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China.
Liu X; Department of Emergency Medicine, Shenzhen University General Hospital, Shenzhen University Clinical Medical Academy, Shenzhen University, Shenzhen, Guangdong Province, People's Republic of China.
Wang K; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China.
Wang C; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China.
Ju X; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China.
Wang T; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China.
Zhou Q; Department of Pulmonary and Critical Care Medicine, NHC Key Laboratory of Respiratory Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China.
Fu X; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China.
Yu J; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China.
Wang Y; Department of Pulmonary and Critical Care Medicine, NHC Key Laboratory of Respiratory Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China.
Pokaż więcej
Źródło:
International journal of nanomedicine [Int J Nanomedicine] 2024 Feb 23; Vol. 19, pp. 1827-1842. Date of Electronic Publication: 2024 Feb 23 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Idiopathic Pulmonary Fibrosis*/genetics
Idiopathic Pulmonary Fibrosis*/therapy
Animals ; Humans ; Mice ; Fibroblasts ; Fibrosis ; Lung/pathology ; Macrophages/metabolism ; Mice, Inbred C57BL ; RNA, Small Interfering/metabolism ; Transforming Growth Factor beta1/metabolism
Czasopismo naukowe
Tytuł:
Mapping the genetic architecture of idiopathic pulmonary fibrosis: Meta-analysis and epidemiological evidence of case-control studies.
Autorzy:
Singh P; Academy of Scientific and Innovative Research (AcSIR), CSIR-HRDC, Ghaziabad, Uttar Pradesh, India; Genomics and Molecular Medicine Unit, CSIR-Institute of Genomics and Integrative Biology (IGIB), New Delhi, India.
Guin D; Department of Biotechnology, Delhi Technological University, Shahbad Daulatpur, Main Bawana Road, New Delhi, India; Genomics and Molecular Medicine Unit, CSIR-Institute of Genomics and Integrative Biology (IGIB), New Delhi, India.
Pattnaik B; Centre of Excellence for Translational Research in Asthma and Lung Diseases, CSIR-Institute of Genomics and Integrative Biology (IGIB), New Delhi, India; Department of Pulmonary, Critical Care and Sleep Medicine, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Kukreti R; Academy of Scientific and Innovative Research (AcSIR), CSIR-HRDC, Ghaziabad, Uttar Pradesh, India; Genomics and Molecular Medicine Unit, CSIR-Institute of Genomics and Integrative Biology (IGIB), New Delhi, India. Electronic address: .
Pokaż więcej
Źródło:
Gene [Gene] 2024 Feb 15; Vol. 895, pp. 147993. Date of Electronic Publication: 2023 Nov 15.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Transforming Growth Factor beta1*/genetics
Idiopathic Pulmonary Fibrosis*/epidemiology
Idiopathic Pulmonary Fibrosis*/genetics
Humans ; Genetic Predisposition to Disease ; Case-Control Studies ; Polymorphism, Genetic ; GTPase-Activating Proteins/genetics
Czasopismo naukowe
Tytuł:
The gene expression of CALD1, CDH2, and POSTN in fibroblast are related to idiopathic pulmonary fibrosis.
Autorzy:
Wu S; Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
Liu M; Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
Zhang M; Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
Ye X; Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
Gu H; Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China.
Jiang C; Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
Zhu H; Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
Ye X; Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
Li Q; Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
Huang X; Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.; Nanjing Institute of Respiratory Diseases, Nanjing, China.
Cao M; Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.; Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.; Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China.; Nanjing Institute of Respiratory Diseases, Nanjing, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Feb 02; Vol. 15, pp. 1275064. Date of Electronic Publication: 2024 Feb 02 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Transforming Growth Factor beta1*/metabolism
Idiopathic Pulmonary Fibrosis*/genetics
Idiopathic Pulmonary Fibrosis*/metabolism
Humans ; Fibroblasts/metabolism ; Collagen/metabolism ; Gene Expression ; Cadherins/genetics ; Cadherins/metabolism ; Calmodulin-Binding Proteins/metabolism ; Cell Adhesion Molecules/metabolism ; Antigens, CD/metabolism
Czasopismo naukowe
Tytuł:
Osteopontin: an essential regulatory protein in idiopathic pulmonary fibrosis.
Autorzy:
Zhu X; Immunology and Reproduction Biology Laboratory & State Key Laboratory of Analytical Chemistry for Life Science, Medical School, Nanjing University, Hankou Road 22, Nanjing, 210093, China.; Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, Nanjing, 210093, China.
Ji J; Immunology and Reproduction Biology Laboratory & State Key Laboratory of Analytical Chemistry for Life Science, Medical School, Nanjing University, Hankou Road 22, Nanjing, 210093, China.; Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, Nanjing, 210093, China.
Han X; Immunology and Reproduction Biology Laboratory & State Key Laboratory of Analytical Chemistry for Life Science, Medical School, Nanjing University, Hankou Road 22, Nanjing, 210093, China. .; Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, Nanjing, 210093, China. .
Pokaż więcej
Źródło:
Journal of molecular histology [J Mol Histol] 2024 Feb; Vol. 55 (1), pp. 1-13. Date of Electronic Publication: 2023 Oct 25.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Osteopontin*/metabolism
Idiopathic Pulmonary Fibrosis*/etiology
Idiopathic Pulmonary Fibrosis*/pathology
Humans ; Inflammation/pathology ; Extracellular Matrix/metabolism ; Fibroblasts/pathology ; Lung/pathology ; Epithelial-Mesenchymal Transition ; Fibrosis
Czasopismo naukowe
Tytuł:
Salvianolic acid B protects against pulmonary fibrosis by attenuating stimulating protein 1-mediated macrophage and alveolar type 2 cell senescence.
Autorzy:
Li Y; School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
Chen R; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Wu J; School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
Xue X; School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
Liu T; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Peng G; School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
Wu R; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Wang L; School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
Jia K; School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
Cai Y; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Li X; School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
Pokaż więcej
Źródło:
Phytotherapy research : PTR [Phytother Res] 2024 Feb; Vol. 38 (2), pp. 620-635. Date of Electronic Publication: 2023 Nov 12.
Typ publikacji:
Journal Article
MeSH Terms:
Lung*/pathology
Idiopathic Pulmonary Fibrosis*/chemically induced
Idiopathic Pulmonary Fibrosis*/drug therapy
Idiopathic Pulmonary Fibrosis*/genetics
Benzofurans*
Depsides*
Middle Aged ; Aged ; Humans ; Mice ; Animals ; Adolescent ; Cellular Senescence/physiology ; Macrophages, Alveolar ; Bleomycin/adverse effects
Czasopismo naukowe
Tytuł:
Spatial targeting of fibrosis-promoting macrophages with nanoscale metal-organic frameworks for idiopathic pulmonary fibrosis therapy.
Autorzy:
Hou J; Immunology and Reproduction Biology Laboratory & State Key Laboratory of Analytical Chemistry for Life Science, Medical School, Nanjing University, Nanjing 210093, China; Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, Nanjing 210093, China; School of Medicine & Holistic Integrative Medicine, Jiangsu Collaborative Innovation Canter of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Cong Y; State Key Laboratory of Pharmaceutical Biotechnology, Chemistry and Biomedicine Innovation Center (ChemBIC), Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing 210093, China.
Ji J; Immunology and Reproduction Biology Laboratory & State Key Laboratory of Analytical Chemistry for Life Science, Medical School, Nanjing University, Nanjing 210093, China; Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, Nanjing 210093, China.
Liu Y; Immunology and Reproduction Biology Laboratory & State Key Laboratory of Analytical Chemistry for Life Science, Medical School, Nanjing University, Nanjing 210093, China; Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, Nanjing 210093, China.
Hong H; State Key Laboratory of Pharmaceutical Biotechnology, Chemistry and Biomedicine Innovation Center (ChemBIC), Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing 210093, China. Electronic address: .
Han X; Immunology and Reproduction Biology Laboratory & State Key Laboratory of Analytical Chemistry for Life Science, Medical School, Nanjing University, Nanjing 210093, China; Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, Nanjing 210093, China. Electronic address: .
Pokaż więcej
Źródło:
Acta biomaterialia [Acta Biomater] 2024 Jan 15; Vol. 174, pp. 372-385. Date of Electronic Publication: 2023 Dec 09.
Typ publikacji:
Journal Article
MeSH Terms:
Metal-Organic Frameworks*/pharmacology
Curcumin*/pharmacology
Curcumin*/therapeutic use
Curcumin*/chemistry
Idiopathic Pulmonary Fibrosis*/drug therapy
Idiopathic Pulmonary Fibrosis*/metabolism
Mice ; Animals ; Macrophages/metabolism ; Peptides/pharmacology
Czasopismo naukowe
Tytuł:
ILD-GAP combined with the monocyte ratio could be a better prognostic prediction model than ILD-GAP in patients with interstitial lung diseases.
Autorzy:
Hirata M; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
Hara Y; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan. .
Fujii H; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
Murohashi K; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
Saigusa Y; Department of Biostatistics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Zhao S; Department of Biostatistics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Kobayashi M; Department of Biostatistics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Nagasawa R; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
Tagami Y; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
Izawa A; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
Otsu Y; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
Watanabe K; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
Horita N; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
Kobayashi N; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
Kaneko T; Department of Pulmonology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
Pokaż więcej
Źródło:
BMC pulmonary medicine [BMC Pulm Med] 2024 Jan 05; Vol. 24 (1), pp. 16. Date of Electronic Publication: 2024 Jan 05.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Diseases, Interstitial*/diagnosis
Idiopathic Pulmonary Fibrosis*/complications
Idiopathic Pulmonary Fibrosis*/diagnosis
Alveolitis, Extrinsic Allergic*/diagnosis
Autoimmune Diseases*
Cardiovascular Diseases*
Humans ; Aged ; Monocytes ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Traditional Chinese medicine inspired dual-drugs loaded inhalable nano-therapeutics alleviated idiopathic pulmonary fibrosis by targeting early inflammation and late fibrosis.
Autorzy:
Zheng M; Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100010, China.; Peking University People's Hospital, Beijing, 100032, China.
Liu K; Division of Pulmonary and Critical Care Medicine, Kunming Children's Hospital, Kunming, 650000, China.
Li L; Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, National Clinical Research Center for Obstetric & Gynecologic Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100032, China. .
Feng C; Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100010, China. .; Peking University People's Hospital, Beijing, 100032, China. .
Wu G; School of Materials Science & Engineering, Beijing Institute of Technology, Beijing, 100081, China. .
Pokaż więcej
Źródło:
Journal of nanobiotechnology [J Nanobiotechnology] 2024 Jan 03; Vol. 22 (1), pp. 14. Date of Electronic Publication: 2024 Jan 03.
Typ publikacji:
Journal Article
MeSH Terms:
NLR Family, Pyrin Domain-Containing 3 Protein*
Idiopathic Pulmonary Fibrosis*/drug therapy
Idiopathic Pulmonary Fibrosis*/chemically induced
Idiopathic Pulmonary Fibrosis*/metabolism
Humans ; Medicine, Chinese Traditional ; Inflammasomes/metabolism ; Reactive Oxygen Species/metabolism ; Quality of Life ; Lung/metabolism ; Fibrosis ; Inflammation/pathology ; p38 Mitogen-Activated Protein Kinases
Czasopismo naukowe
Tytuł:
Metformin enhanced the effect of pirfenidone on pulmonary fibrosis in mice.
Autorzy:
Liu N; Department of Critical Care Medicine, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China.
Song Y; Cardiovascular Institute, Chest Hospital, Tianjin University, Tianjin, China.
Liu T; Cardiovascular Institute, Chest Hospital, Tianjin University, Tianjin, China.
Wang H; Cardiovascular Institute, Chest Hospital, Tianjin University, Tianjin, China.
Yu N; Department of Critical Care Medicine, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China.
Ma H; Department of Respiratory and Critical Care Medicine, Chest Hospital, Tianjin University, Tianjin, China.
Pokaż więcej
Źródło:
The clinical respiratory journal [Clin Respir J] 2024 Jan; Vol. 18 (1), pp. e13731.
Typ publikacji:
Journal Article
MeSH Terms:
Metformin*/pharmacology
Metformin*/therapeutic use
Idiopathic Pulmonary Fibrosis*/chemically induced
Idiopathic Pulmonary Fibrosis*/drug therapy
Idiopathic Pulmonary Fibrosis*/pathology
Pyridones*
Humans ; Mice ; Animals ; Lung/pathology ; Superoxide Dismutase/pharmacology ; Mice, Inbred C57BL
Czasopismo naukowe
Tytuł:
Effect of antifibrotic agents on postoperative complications after lung transplantation for idiopathic pulmonary fibrosis.
Autorzy:
Moncomble E; Service de Pneumologie B et Transplantation pulmonaire, Hôpital Bichat, APHP Nord-Université Paris Cité, Paris, France.
Weisenburger G; Service de Pneumologie B et Transplantation pulmonaire, Hôpital Bichat, APHP Nord-Université Paris Cité, Paris, France.
Picard C; Service de Pneumologie, Hôpital Foch, Suresnes, France.
Dégot T; Service de Pneumologie, Nouvel Hôpital Civil, Strasbourg, France.
Reynaud-Gaubert M; Service de Pneumologie-Maladies Pulmonaires Rares-Centre de Transplantation Pulmonaire, Hôpital Nord, Marseille, France.
Nieves A; Service de Pneumologie-Maladies Pulmonaires Rares-Centre de Transplantation Pulmonaire, Hôpital Nord, Marseille, France.
Mornex JF; Hospices Civils de Lyon, Lyon, France.; Université de Lyon, Université Lyon 1, Lyon, France.
Dauriat G; Service de Transplantation, Chirurgie Thoracique et Vasculaire, Hôpital Marie Lannelongue, Le Plessis Robinson, France.
Messika J; Service de Pneumologie B et Transplantation pulmonaire, Hôpital Bichat, APHP Nord-Université Paris Cité, Paris, France.
Godet C; Service de Pneumologie B et Transplantation pulmonaire, Hôpital Bichat, APHP Nord-Université Paris Cité, Paris, France.
Hirschi S; Service de Pneumologie, Nouvel Hôpital Civil, Strasbourg, France.
Le Pavec J; Service de Transplantation, Chirurgie Thoracique et Vasculaire, Hôpital Marie Lannelongue, Le Plessis Robinson, France.
Borie R; Service de Pneumologie A, Hôpital Bichat, Paris, France.
Mordant P; Service de Chirurgie Thoracique, Hôpital Bichat, Paris, France.
Lortat-Jacob B; Service de Réanimation Chirurgicale, Hôpital Bichat, Paris, France.
Mal H; Service de Pneumologie B et Transplantation pulmonaire, Hôpital Bichat, APHP Nord-Université Paris Cité, Paris, France.
Bunel V; Service de Pneumologie B et Transplantation pulmonaire, Hôpital Bichat, APHP Nord-Université Paris Cité, Paris, France.
Pokaż więcej
Źródło:
Respirology (Carlton, Vic.) [Respirology] 2024 Jan; Vol. 29 (1), pp. 71-79. Date of Electronic Publication: 2023 Oct 03.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Primary Graft Dysfunction*/drug therapy
Primary Graft Dysfunction*/etiology
Idiopathic Pulmonary Fibrosis*/drug therapy
Idiopathic Pulmonary Fibrosis*/surgery
Lung Transplantation*/adverse effects
Humans ; Antifibrotic Agents ; Retrospective Studies ; Postoperative Complications/epidemiology ; Postoperative Complications/etiology ; Pyridones/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł:
The preventative effects of statin on lung cancer development in patients with idiopathic pulmonary fibrosis using the National Health Insurance Service Database in Korea.
Autorzy:
Lee YJ; Department of Internal Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Republic of Korea.
Kang N; Department of Statistics and Data Science, Yonsei University, Seoul, Republic of Korea.
Nam J; Department of Internal Medicine, Division of Respiratory, Allergy and Critical Care Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Lee EG; Department of Internal Medicine, Division of Respiratory, Allergy and Critical Care Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Republic of Korea.
Ryoo J; Department of Internal Medicine, Division of Respiratory, Allergy and Critical Care Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Republic of Korea.
Kwon SS; Department of Internal Medicine, Division of Respiratory, Allergy and Critical Care Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Republic of Korea.
Kim YH; Department of Internal Medicine, Division of Respiratory, Allergy and Critical Care Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Republic of Korea.
Kang HS; Department of Internal Medicine, Division of Respiratory, Allergy and Critical Care Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Republic of Korea.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 13; Vol. 19 (3), pp. e0299484. Date of Electronic Publication: 2024 Mar 13 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/complications
Lung Neoplasms*/epidemiology
Lung Neoplasms*/prevention & control
Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use
Idiopathic Pulmonary Fibrosis*/complications
Idiopathic Pulmonary Fibrosis*/drug therapy
Idiopathic Pulmonary Fibrosis*/diagnosis
Humans ; Female ; Male ; National Health Programs ; Republic of Korea/epidemiology ; Retrospective Studies
Czasopismo naukowe
Tytuł:
The tolerability and efficacy of antifibrotic therapy in patients with idiopathic pulmonary fibrosis: Results from a real-world study.
Autorzy:
Zhao R; Beijing University of Chinese Medicine, Beijing, 100029, China; National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, 100029, China.
Xie B; National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, 100029, China.
Wang X; Beijing University of Chinese Medicine, Beijing, 100029, China; National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, 100029, China.
Zhang X; National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, 100029, China; Department of Clinical Research and Data Management, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, 100029, China.
Ren Y; National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, 100029, China.
Wang C; Beijing University of Chinese Medicine, Beijing, 100029, China; National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, 100029, China. Electronic address: .
Dai H; National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, 100029, China. Electronic address: .
Pokaż więcej
Źródło:
Pulmonary pharmacology & therapeutics [Pulm Pharmacol Ther] 2024 Mar; Vol. 84, pp. 102287. Date of Electronic Publication: 2024 Jan 17.
Typ publikacji:
Journal Article
MeSH Terms:
Idiopathic Pulmonary Fibrosis*
Humans ; Treatment Outcome ; Fibrosis ; Survival Rate ; Pyridones/adverse effects ; Japan
Czasopismo naukowe
Tytuł:
Unraveling the interplay between vital organelle stress and oxidative stress in idiopathic pulmonary fibrosis.
Autorzy:
Mohanan A; Division of Toxicology and Experimental Medicine, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow 226031, India.
Washimkar KR; Division of Toxicology and Experimental Medicine, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow 226031, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
Mugale MN; Division of Toxicology and Experimental Medicine, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow 226031, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India. Electronic address: .
Pokaż więcej
Źródło:
Biochimica et biophysica acta. Molecular cell research [Biochim Biophys Acta Mol Cell Res] 2024 Mar; Vol. 1871 (3), pp. 119676. Date of Electronic Publication: 2024 Jan 17.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Oxidative Stress*
Idiopathic Pulmonary Fibrosis*
Humans ; Reactive Oxygen Species ; Mitochondria ; Inflammation
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies